Drug
Regn7999
Regn7999: highest development phase Phase 1, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| REGN7999 NCT05481333 | Phase 1 | Healthy |
Latest
No recent events.
Follow Regn7999 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.